Company intelligence / Profile preview

2D Genomics

Fremont, California, United States

Ownership: Private
Employees: ~2
Development stage: Other

Overview

2D Genomics developed enzymatic technologies for RNA-seq/NGS library preparation that improve sensitivity and library diversity; these technologies were commercialized post-acquisition by Bio-Rad in the SEQuoia Complete Stranded RNA Library Prep Kit for research use in transcriptomics and biomarker discovery, not as therapeutics.[3]

Modalities: ToolsReagentsEnzymes
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on 2D Genomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2D Genomics.

Explore the full profile